GeneDx Holdings Corp (WGS)
19.00
-1.87
(-8.96%)
USD |
NASDAQ |
May 02, 10:24
GeneDx Holdings Cash from Investing (TTM): -42.42M for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | -42.42M |
| December 31, 2023 | -43.73M |
| September 30, 2023 | -41.70M |
| June 30, 2023 | -18.85M |
| March 31, 2023 | -137.88M |
| Date | Value |
|---|---|
| December 31, 2022 | -141.33M |
| September 30, 2022 | -146.18M |
| June 30, 2022 | -145.52M |
| March 31, 2022 | -19.70M |
| December 31, 2021 | -20.79M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-146.18M
Minimum
Sep 2022
-18.85M
Maximum
Jun 2023
-75.81M
Average
-43.07M
Median
Cash from Investing (TTM) Benchmarks
| American Well Corp | -19.17M |
| GoodRx Holdings Inc | -55.77M |
| Privia Health Group Inc | -42.97M |
| Doximity Inc | 94.15M |
| FOXO Technologies Inc | -0.14M |